Affymax Inc.
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Affymax Inc. (AFFY) - Total Assets
Latest total assets as of June 2014: $5.38 Million USD
Based on the latest financial reports, Affymax Inc. (AFFY) holds total assets worth $5.38 Million USD as of June 2014.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Affymax Inc. - Total Assets Trend (2001–2013)
This chart illustrates how Affymax Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Affymax Inc. - Asset Composition Analysis
Current Asset Composition (December 2013)
Affymax Inc.'s total assets of $5.38 Million consist of 84.9% current assets and 15.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 75.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2013)
This chart illustrates how Affymax Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Affymax Inc.'s current assets represent 84.9% of total assets in 2013, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 75.2% of total assets in 2013, up from 0.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Affymax Inc. Competitors by Total Assets
Key competitors of Affymax Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Affymax Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Affymax Inc. generates 0.18x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Affymax Inc. is currently not profitable relative to its asset base.
Affymax Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 20.81 | 0.86 | 1.06 |
| Quick Ratio | 20.81 | 0.86 | 1.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.24 Million | $ -1.90 Million | $ 7.14 Million |
Affymax Inc. - Advanced Valuation Insights
This section examines the relationship between Affymax Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.56 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -93.7% |
| Total Assets | $7.44 Million |
| Market Capitalization | $23.47 USD |
Valuation Analysis
Below Book Valuation: The market values Affymax Inc.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Affymax Inc.'s assets decreased by 93.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Affymax Inc. (2001–2013)
The table below shows the annual total assets of Affymax Inc. from 2001 to 2013.
| Year | Total Assets | Change |
|---|---|---|
| 2013-12-31 | $7.44 Million | -93.70% |
| 2012-12-31 | $118.22 Million | -0.65% |
| 2011-12-31 | $119.00 Million | -9.43% |
| 2010-12-31 | $131.39 Million | -37.88% |
| 2009-12-31 | $211.51 Million | +26.11% |
| 2008-12-31 | $167.72 Million | -25.72% |
| 2007-12-31 | $225.79 Million | -9.68% |
| 2006-12-31 | $249.99 Million | +310.09% |
| 2005-12-31 | $60.96 Million | +119.85% |
| 2004-12-31 | $27.73 Million | -24.87% |
| 2002-12-31 | $36.91 Million | -43.01% |
| 2001-12-31 | $64.76 Million | -- |